The New York State Department of Health today announced that it has authorized five additional registered organizations (ROs) to manufacture and dispense medical marijuana in New York State, an initiative aimed at improving patient access and the geographic distribution of dispensing facilities across the state.
The New York Medical Cannabis Industry Association, acting on behalf of four of the five original medical marijuana companies, sued the state in April to try to stop it from issuing new licenses.
State Sen. Diane Savino, a Staten Island Democrat who sponsored the bill creating the medical marijuana program, had mixed feelings about the expansion of companies.
Fiorello Pharmaceuticals, a Manhattan-based company, will operate a manufacturing facility in Schenectady County and dispensing facilities in Nassau, Monroe, New York and Saratoga counties.
As Fiorella co-CEO Eric Sirota told reporters, "what distinguishes us from the other companies in the market is that all of our facilities will be located in medical buildings, in academic medical settings". NY launched its medical marijuana program previous year. Among the dispensaries will be two at unspecified locations in Dutchess County - one run by Citiva, the other by Valley Agriceuticals, state health officials said.
Scientists corrects disease-causing gene mutation in human embryos
The researchers found that 72.4 percent of the embryos, not 50 percent as would have been expected, were free of the errant gene. The technique could be used through in vitro fertilization to cure thousands of diseases caused by mutations in single genes.
As of Tuesday, there were 25,736 certified patients and 1,139 registered practitioners participating in New York's Medical Marijuana Program, according to the Department of Health.
Minnesota regulators this year tightened state oversight of medical marijuana growers by adding a broader menu of sanctions and fines for violations and requiring that companies use "seed to sale" tracking software to monitor the whereabouts of their products. That company plans to grow marijuana in Orange County. As of August 1, there are 25,736 certified patients and 1,139 registered practitioners in the program.
Since March, there has been a 72 percent increase in certified patients. The lone exception is New York Canna, which will have its manufacturing facility in Onondaga County.
The increased number of patients coincides with the addition of chronic pain as a qualifying condition.
It was not immediately clear where PalliaTech NY's Ulster County operation will be.